Skip to main content
OpenTrials
Completed

NCT Number: NCT05808140

Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery

In endoscopic spinal nerve root decompression surgery, the intraoperative nerve exploration is time-consuming and critical. According to statistics, the incidence of nerve root injury under spinal endoscope is 1.8-2.5%. Damage to nerve roots may lead to postoperative sensory retardation and motor weakness, thereby impairing the physical function of patients. A real-time auxiliary intraoperative nerve identification technology is necessary.

In this prospective, open-label, randomized, parallel controlled trial, 40 patients who undergo endoscopic spinal surgery are included. Subjects are randomly divided into control group and low, medium and high Indocyanine green(ICG) preoperative administration experimental group. Standard endoscopic spinal surgery is performed in the control group. Patients in the experimental group received an intravenous injection of ICG before surgery, and a standard endoscopic spinal surgery is performed with the use of a fluoroscopic endoscopic surgical imaging system to assist the surgeon in identifying and protecting the nerve roots.

The main objectives of this experiment are (i) to explore the safety and feasibility of ICG fluorescence imaging to assist in nerve root identification during endoscopic spinal surgery and (ii) the effectiveness of this technique for endoscopic search for nerve roots. The secondary objective is to explore the optimal ICG dosing regimen.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University

Wuhan, Hubei, 430062, China

About this study

With the accelerated pace of the global aging society, the prevalence of degenerative diseases is increasing. At present, spinal degenerative diseases caused by body degeneration have become the most common type. With the continuous deepening of the research on spinal degenerative diseases and the continuous development, update and promotion of minimally invasive surgery technology and instruments, minimally invasive surgery has attracted more and more attention of spine surgeons due to its advantages of rapid recovery, small trauma and fewer complications.

The core of endoscopic spinal surgery is nerve root decompression. The procedure is centered on the nerve roots, which can be damaged with the slightest carelessness. According to statistics, the incidence of nerve root injury under spinal endoscope is 1.8-2.5%. Most of the injuries include the stimulation and edema of the nerve root during the operation, which may lead to postoperative sensory retardation and motor weakness, which will damage the patient's physical function and reduce overall satisfaction. The intraoperative nerve exploration is time-consuming and critical, and the variability of the patient's nerve anatomy will also add difficulties to the operation. A real-time auxiliary intraoperative nerve identification technology is necessary.

With the progress of optical technology, fluorescent-guided surgery has shown considerable prospects in assisting in identifying nerves. Indocyanine green (ICG) is the only fluorophore approved by the US Food and Drug Administration (FDA) for intraoperative near-infrared imaging. It can emit near-infrared light after being irradiated by excitation light, which has the characteristics of high penetration depth, low spontaneous fluorescence and high sensitivity. At present, ICG near-infrared fluorescence imaging has been applied to tumor detection, lymphangiography and vascular perfusion evaluation. In recent years, more and more researchers have paid attention to the application value of ICG fluorescence imaging in neuroimaging. It has been applied to clinical research of thoracic sympathetic ganglion, facial nerve, phrenic nerve and pelvic nerve.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with lumbar disc herniation based on symptoms and Imaging examination
  • Patients undergo endoscopy spinal surgery for nerve root decompression
  • Patients have no clear contraindications to surgery, and has the ability to understand and act and has informed consent, and can participate in all study follow-up voluntarily and signe a written informed consent form.

Exclusion criteria

  • The patients have thyroid related diseases, including autonomous nodules
  • Patients are allergic to iodine or shellfish
  • Patients have ankylosing spondylitis, lumbar instability or bony spinal stenosis
  • Patients have diabetes, vascular related diseases, or abnormal liver and kidney function
  • Difficulty in tolerating anaesthesia
  • Pregnant or lactating women
  • Patients are unable to communicate or do not follow directions
  • The investigators consider the patient unsuitable to participate in this study

Treatment and study plan

Indocyanine green

Drug

Preoperatively, a single dose of intravenous indocyanine green is administered

Other names: ICG

Fluorescence Imaging

Device

Use of a spinal endoscopic fluorescent imaging system to assist surgeons in identifying and protecting nerve roots intraoperatively

Primary outcomes

  1. Fluorescence imaging rate of nerve roots

    Time frame: Intraoperative

    Number of the nerve roots with fluorescent imaging in the experimental group/Total nerve roots in the experimental group×100%

  2. Fluorescence signal ratio of nerve root to back fluorescence

    Time frame: Immediately postoperative

    Nerve root fluorescence intensity/Background fluorescence intensity

  3. Time taken to find the nerve root endoscopically

    Time frame: Intraoperative

    Time from opening the ligamentum flavum to finding the nerve root in spinal endoscopic procedures

Secondary outcomes

  1. ICG-related adverse reactions

    Time frame: Immediately after ICG administration to 30 min after administration

  2. Visual analogue pain scale (Visual analogue scale, VAS)

    Time frame: 1 day before surgery, 1 day after surgery, 1 week after surgery, 1 month after surgery

    The VAS pain score uses the VAS scale, with end 0 being no pain, graded 1-4 being mild pain, 5-6 being moderate pain, 7-9 being severe pain, and end 10 being unbearable pain. The higher the score, the more severe the pain level.

  3. Oswestry disability index(ODI)

    Time frame: 1 day before surgery, 1 day after surgery, 1 week after surgery, 1 month after surgery

    The ODI score is based on the Oswestry Disability Index questionnaire. The lowest score was 0% and the highest score was 100%, with higher scores indicating more severe functional impairment.

  4. Surgical complications

    Time frame: Within 1 week after surgery

    Record any surgical complications that occurred in the patient within 1 week after surgery

  5. Length of surgery

    Time frame: From the beginning to the end of the surgery

    Use a timer to record the length of the surgery (accurate to the minute)

Sponsors and collaborators

Lead sponsor

Zhongnan Hospital

Other

Registry information

Official study title

Clinical Application of Indocyanine Green Fluorescence Imaging to Assist Identification of Nerve Roots in Endoscopic Spinal Surgery

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Apr 11, 2023
Registry last updated
Dec 19, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.